August 12, 2025

FDA Approves First Therapy for Non-cystic Fibrosis Bronchiectasis

Brensocatib (Brinsupri) will offer a new treatment option for patients 12 years and older.

Conexiant

August 11, 2025

FDA Grants Priority Review to Gepotidacin for Gonorrhea

First potential oral treatment for gonorrhea supported by positive phase 3 trial results.

Conexiant

August 11, 2025

CDC Shooting Deepens Crisis in HIV Prevention

CDC workers describe stalled HIV prevention projects, morale collapse, and heightened safety fears after budget cuts, layoffs, and a deadly shooting at agency headquarters.

KFF Health News

August 07, 2025

Flu Treatment Linked to Lower Neuropsychiatric Risk in Pediatric and Adolescent Patients

Subgroup analyses demonstrated a greater reduction in neurologic events than psychiatric events, though the reduction in psychiatric events was not statistically significant.

Conexiant

August 06, 2025

Fewer Risks with Unilateral Robotic Tonsil Surgery

Unilateral transoral robotic surgery for HPV-positive tonsillar squamous cell carcinoma is associated with fewer complications, shorter hospital stays, and comparable survival compared with bilateral surgery.

Conexiant

August 06, 2025

UV Light Linked With Lower Respiratory Infection Rates 

Researchers found that germicidal UV light modestly reduced total respiratory infections in long-term care facilities for older adults.

Conexiant

August 04, 2025

Beta-HPV–Driven SCC Resolved After TCR Signaling Correction

Case study shows cutaneous squamous cell carcinoma linked to beta-human papillomavirus cleared following T-cell immune restoration.

Conexiant

August 01, 2025

UTI Linked to Short-Term Spike in MI, Storke

Analysis of microbiologically confirmed UTIs reveals a transient increase in cardiovascular event rates, especially within 7 days of infection onset.

Conexiant

July 24, 2025

HHS Ends Thimerosal Use in Flu Vaccines

The U.S. Department of Health and Human Services has adopted a CDC advisory panel recommendation to remove thimerosal from all influenza vaccines, transitioning entirely to mercury-free, single-dose formulations.

Conexiant